Your browser doesn't support javascript.
loading
The DAPA-DIET study: Metabolic response to Dapagliflozin combined with dietary carbohydrate restriction in patients with Type 2 Diabetes Mellitus and Obesity-A longitudinal cohort study.
Hanson, Petra; Randeva, Harpal; Cuthbertson, Dan J; O'Hare, Paul J; Parsons, Nick; Chatha, Kamaljit; Reidy, Gemma; Weickert, Martin O; Barber, Thomas M.
Afiliação
  • Hanson P; Warwick Medical School, University of Warwick, Coventry, UK.
  • Randeva H; Warwickshire Institute for the Study of Diabetes Endocrinology and Metabolism, University Hospitals Coventry and Warwickshire, Coventry, UK.
  • Cuthbertson DJ; Warwick Medical School, University of Warwick, Coventry, UK.
  • O'Hare PJ; Warwickshire Institute for the Study of Diabetes Endocrinology and Metabolism, University Hospitals Coventry and Warwickshire, Coventry, UK.
  • Parsons N; Institute of Cardiovascular and Metabolic Medicine, University of Liverpool, Liverpool, UK.
  • Chatha K; Department of Endocrinology, Liverpool University Hospital NHS Foundation Trust, Liverpool, UK.
  • Reidy G; Warwick Medical School, University of Warwick, Coventry, UK.
  • Weickert MO; Warwickshire Institute for the Study of Diabetes Endocrinology and Metabolism, University Hospitals Coventry and Warwickshire, Coventry, UK.
  • Barber TM; Warwick Medical School, University of Warwick, Coventry, UK.
Endocrinol Diabetes Metab ; 5(6): e381, 2022 11.
Article em En | MEDLINE | ID: mdl-36266774

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Endocrinol Diabetes Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Inibidores do Transportador 2 de Sódio-Glicose Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Endocrinol Diabetes Metab Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Reino Unido